Literature DB >> 31984452

Introduction by the Guest Editor: Recent advances in biology and treatment of multiple myeloma.

Hirokazu Tanaka1.   

Abstract

Entities:  

Year:  2020        PMID： 31984452     DOI： 10.1007/s12185-020-02830-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  7 in total

1.  Progress and Paradigms in Multiple Myeloma.

Authors:  Kenneth C Anderson
Journal:  Clin Cancer Res       Date:  2016-11-15       Impact factor: 12.531

Review 2.  International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.

Authors:  Shaji Kumar; Bruno Paiva; Kenneth C Anderson; Brian Durie; Ola Landgren; Philippe Moreau; Nikhil Munshi; Sagar Lonial; Joan Bladé; Maria-Victoria Mateos; Meletios Dimopoulos; Efstathios Kastritis; Mario Boccadoro; Robert Orlowski; Hartmut Goldschmidt; Andrew Spencer; Jian Hou; Wee Joo Chng; Saad Z Usmani; Elena Zamagni; Kazuyuki Shimizu; Sundar Jagannath; Hans E Johnsen; Evangelos Terpos; Anthony Reiman; Robert A Kyle; Pieter Sonneveld; Paul G Richardson; Philip McCarthy; Heinz Ludwig; Wenming Chen; Michele Cavo; Jean-Luc Harousseau; Suzanne Lentzsch; Jens Hillengass; Antonio Palumbo; Alberto Orfao; S Vincent Rajkumar; Jesus San Miguel; Herve Avet-Loiseau
Journal:  Lancet Oncol       Date:  2016-08       Impact factor: 41.316

Review 3.  A review on tumor heterogeneity and evolution in multiple myeloma: pathological, radiological, molecular genetics, and clinical integration.

Authors:  Christian M Schürch; Leo Rasche; Leonie Frauenfeld; Niels Weinhold; Falko Fend
Journal:  Virchows Arch       Date:  2019-12-17       Impact factor: 4.064

Review 4.  Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting.

Authors:  Paul G Richardson; Jesus F San Miguel; Philippe Moreau; Roman Hajek; Meletios A Dimopoulos; Jacob P Laubach; Antonio Palumbo; Katarina Luptakova; Dorothy Romanus; Tomas Skacel; Shaji K Kumar; Kenneth C Anderson
Journal:  Blood Cancer J       Date:  2018-11-09       Impact factor: 11.037

5.  Genomic patterns of progression in smoldering multiple myeloma.

Authors:  Niccolò Bolli; Francesco Maura; Stephane Minvielle; Dominik Gloznik; Raphael Szalat; Anthony Fullam; Inigo Martincorena; Kevin J Dawson; Mehmet Kemal Samur; Jorge Zamora; Patrick Tarpey; Helen Davies; Mariateresa Fulciniti; Masood A Shammas; Yu Tzu Tai; Florence Magrangeas; Philippe Moreau; Paolo Corradini; Kenneth Anderson; Ludmil Alexandrov; David C Wedge; Herve Avet-Loiseau; Peter Campbell; Nikhil Munshi
Journal:  Nat Commun       Date:  2018-08-22       Impact factor: 14.919

Review 6.  Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future Perspectives.

Authors:  Alessandra Romano; Giuseppe Alberto Palumbo; Nunziatina Laura Parrinello; Concetta Conticello; Marina Martello; Carolina Terragna
Journal:  Front Oncol       Date:  2019-08-20       Impact factor: 6.244

Review 7.  Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma.

Authors:  Francesca Bonello; Roberto Mina; Mario Boccadoro; Francesca Gay
Journal:  Cancers (Basel)       Date:  2019-12-19       Impact factor: 6.639
  7 in total
  1 in total

Review 1.  Theranostic Potentials of Gold Nanomaterials in Hematological Malignancies.

Authors:  Md Salman Shakil; Mahruba Sultana Niloy; Kazi Mustafa Mahmud; Mohammad Amjad Kamal; Md Asiful Islam
Journal:  Cancers (Basel)       Date:  2022-06-21       Impact factor: 6.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.